Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Symbiosis Appoints Jay Chima as VP, Business Development | Contract Pharma
Breaking News, Promotions & Moves

Symbiosis Appoints Jay Chima as VP, Business Development

Chima brings more than 16 years of commercial experience across pharma, biotech and CDMO markets.

Jay Chima.

Symbiosis Pharmaceutical Services, a specialist aseptic fill-finish Contract Development and Manufacturing Organization (CDMO), has appointed Jay Chima as Vice President, Business Development, bringing more than 16 years of commercial experience to support the company’s next phase of growth and strengthen partnerships with pharmaceutical and biotechnology innovators.

Based in London, Chima will work across Symbiosis’ commercial organization to strengthen relationships with existing customers, establish new strategic partnerships and provide market insight that supports the company’s continued growth and future investment plans.

Joanne Anderson, Chief Commercial Officer at Symbiosis, said: “Jay brings a proven track record of building strategic partnerships, identifying growth opportunities and delivering commercial success across multiple pharmaceutical sectors. His experience across both emerging biotechnology companies and global pharmaceutical organizations gives him a valuable understanding of the challenges customers face at different stages of development.”

“We’re delighted to welcome him to the team and look forward to the contribution he’ll make in supporting our long-term growth ambitions,” she added.

Experience

Chima joins Symbiosis from Recipharm, where he served as Business Development Director and prior to that he held senior commercial positions at MedPharm and Advanz Pharma, building extensive experience supporting organizations ranging from emerging biotechnology companies to global pharmaceutical groups.

Commenting on his appointment, Chima said: “What attracted me to Symbiosis was its unique combination of technical capability, proven delivery, agility and customer focus. It occupies what I believe is the sweet spot within the CDMO sector; large enough to support complex programs and commercial ambitions, yet agile enough to respond quickly to customer needs and provide the attention many drug developers are seeking.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters